Serum sickness in a dog associated with antivenin therapy for snake bite caused by Crotalus adamanteus

Journal of Veterinary Emergency and Critical Care

Volumn 15, Issue 3, 2005, Pages 206-212

  Berdoulay, Paul ^a   Schaer, Michael ^a   Starr, Jessica ^a  

^a University of Florida   (United States)

Author keywords

Crotalidae polyvalent; Hypersensitivity reaction; Rattlesnake

Indexed keywords

CANIS FAMILIARIS; CROTALUS ADAMANTEUS;

EID: 27744433728     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2005.00135.x     Document Type: Article

References (33)

1. Litovitz TL, Klein-Schwartz W, White S, et al. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2001; 19(5):337-395.
2. Aroch I, Harms S. Retrospective study of the epidemiological, clinical, haematological and biochemical findings in 109 dogs poisoned by Vipera xanthina palestinae. Vet Rec 1999; 144:532-535.
3. Dart RC, McNally J. Efficacy, safety and use of snake antivenom in the United States. Ann Emerg Med 2001; 37(2):181-195.
4. Karlson-Stiber C, Persson H. Antivenom treatment in Vipera berus envenoming - report of 30 cases. J Intern Med 1994; 235(1):57-61.
5. Package insert, antivenin (Crotalidae) Polyvalent (North and South American Snakebite Antiserum), Fort Dodge Laboratories Inc., Fort Dodge, IA, 2001.
6. Mirtschin PJ, Masci P, Paton DC, et al. Snake bites recorded by veterinary practices in Australia. Aust Vet J 1998; 26(3):276-281.
7. Schaer M. Eastern diamondback rattlesnake envenomation of 20 dogs. Compend Cont Ed Pract Vet 1985; 6(11):997-1007.
8. Hackett TB, Wingfield WE, Mazzaterro EM, et al. Clinical findings associated with prairie rattlesnake bites in dogs: 100 cases (1989-1998). J Am Vet Med Assoc 2002; 220(11):1675-1680.
9. Walter FG, Fernandez MC, Haddad LM. Natural and environmental toxins. North American venomous snakebite, In: Haddad LM, et al., ed. Clinical Management of Poisoning and Drug Overdose, 3rd edn. Philadelphia: WB Saunders Co.; 1998, pp. 333-352.
10. Clark RF, Selden BS, Furbee B. The incidence of wound infection following crotalid envenomation. J Emerg Med 1993; 11(5):583-586.
11. Slauson DO, Cooper BJ. Mechanisms of Disease: A Textbook of Comparative General Pathology, 2nd edn. Baltimore, MD: Williams and Wilkins; 1990, pp. 330-376.
12. Offerman SR, Smith TS, Derlet RW. Does the aggressive use of polyvalent antivenin for rattlesnake bites result in serious acute side effects? West J Med 2001; 175(2):88-91.
13. Dart RC, Seifert SA, Boyer LV, et al. A randomized multicenter trial of crotalinae polyvalent immune Fab (Ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med 2001; 161(16):2030-2036.
14. Jurkovich GJ, Luterman A, McCullar K, et al. Complications of crotalidae antivenin treatment. J Trauma 1988; 28:1032-1037.
15. Wingert WA, Chan L. Rattlesnake bites in Southern California and rationale for recommended treatment. West J Med 1988; 148(1): 37-44.
16. White RR, Weber RA. Poisonous snakebite in central Texas. Ann Surg 1991; 213(5):466-471.
17. Dart RC, Gomez HF, Daly FS. Reptile bites, In: Tintanelli JE. ed. Emergency Medicine: A Comprehensive Study Guide, 5th edn. New York, NY: McGraw-Hill; 2000, pp. 1251-1256.
18. Lin RY, Curry A, Pesola GR, et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 2000; 36(5):462-468.
19. Frank MM, Lawley TJ. Immune complexes and allergic disease, In: Parker CW. ed. Clinical Immunology. Philadelphia, PA: WB Saunders; 1980, pp. 702-711.
20. Sutherland SK. Antivenom use in Australia. Premedication, adverse reactions and the use of venom detection kits. Med J Aust 1992; 157:734-739.
21. LoVecchio F, Welch S, Klemens J, et al. Incidence of immediate and delayed hypersensitivity to centruroides antivenom. Ann Emerg Med 1999; 34(5):615-619.
22. Corrigan P, Russell FE, Wainschel J. Clinical reactions to antivenin. Toxicon 1978; 16:457-465.
23. LoVecchio F, DeBus DM. Snakebite envenomation in children: a 10-year retrospective review. Wilderness Environ Med 2001; 12(3):184-189.
24. Ruha AM, Curry SC, Beuhler M, et al. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med 2002; 39(6):648-650.
25. Clark RF, McKinney PE, Chase PB, et al. Immediate and delayed allergic reactions to crotalidae polyvalent immune Fab (ovine) antivenom. Ann Emerg Med 2002; 39(6):671-676.
26. Berzofsky JA, Berkower IJ, Epstein SL. Antigen-antibody interactions and monoclonal antibodies, In: Paul WE. ed. Fundamental Immunology, 3rd edn. New York, NY: Raven Press Ltd.; 1993, pp. 421-465.
27. Lawley TJ, Bielory L, Gascon P, et al. A prospective clinical and immunologic analysis of patients with serum sickness. N Eng J Med 1984; 311(22):1407-1413.
28. Fauci AS. The vasculitis syndromes, In: Fauci AS, Braunwald E, Isselbacher KJ, et al., eds. Harrison's Principles of Internal Medicine, 14th edn. New York, NY: McGraw-Hill; 1998, pp. 1919-1920.
29. Gitlin JD. Allergy and immunology, In: Rudolph CD, et al., ed. Rudolph's Pediatrics, 21st edn. New York, NY: McGraw-Hill; 2002, pp. 787-824.
30. Nielsen H, Sorensen H, Faber V, et al. Circulating immune complexes, complement activation kinetics and serum sickness following treatment with heterologous anti-snake venom globulin. Scand J Immunol 1978; 7(1):25-33.
31. Riedl MA, Casillas AM. Adverse drug reactions: types and treatment options. Am Fam Physician 2003; 68(9):1781-1790.
32. Bielory L, Gascon P, Lawley TJ, et al. Human serum sickness: a prospective analysis of 35 patients treated with equine antithymocyte globulin for bone marrow failure. Medicine 1988; 67(1): 40-57.
33. Nizze H. Experimental foreign serum pancreatitis. Histologic and histochemical findings in the exocrine pancreas of the mouse after repeated intraperitoneal injections of serum of other species. Zentra Allg Pathol 1975; 119(4):294-302.